The following are recent financial reports as posted by selected Utah corporations:
Clene
Clene Inc., based in Salt Lake City, reported a net loss of $39.4 million, or $5.67 per share, for the fiscal year ended Dec. 31. That compares with a net loss of $49.5 million, or $9.43 per share, for 2023.
Revenue in 2024 totaled $342,000, down from $654,000 in 2023.
Clene and its wholly owned subsidiary, Clene Nanomedicine Inc., is a Please log in to see the rest of this story.
